Resultaterne ved behandling af andre typer koagulationsforstyrrelser og af patienter med andre former for protein C- mangel var ikke tilstrækkelige til at foretage en fuldstændig vurdering af anvendelsen af CEPROTIN hos disse grupper.
The results in the treatment of other types of clotting disorders, and of patients with other protein C deficiencies, were not sufficient to assess completely the use of CEPROTIN in these groups.